- Home
- LPCN vs YMAT Comparison
LPCN vs YMAT Comparison
Compare LPCN & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- YMAT
- Stock Information
- Founded
- LPCN 1997
- YMAT 1970
- Country
- LPCN United States
- YMAT Taiwan
- Employees
- LPCN N/A
- YMAT N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- YMAT Recreational Games/Products/Toys
- Sector
- LPCN Health Care
- YMAT Consumer Discretionary
- Exchange
- LPCN Nasdaq
- YMAT Nasdaq
- Market Cap
- LPCN 13.8M
- YMAT 15.3M
- IPO Year
- LPCN N/A
- YMAT 2025
- Fundamental
- Price
- LPCN $3.18
- YMAT $0.80
- Analyst Decision
- LPCN Strong Buy
- YMAT
- Analyst Count
- LPCN 1
- YMAT 0
- Target Price
- LPCN $7.00
- YMAT N/A
- AVG Volume (30 Days)
- LPCN 54.7K
- YMAT 2.0M
- Earning Date
- LPCN 11-06-2025
- YMAT 04-29-2026
- Dividend Yield
- LPCN N/A
- YMAT N/A
- EPS Growth
- LPCN N/A
- YMAT N/A
- EPS
- LPCN N/A
- YMAT 0.07
- Revenue
- LPCN $4,322,693.00
- YMAT $17,563,985.00
- Revenue This Year
- LPCN N/A
- YMAT N/A
- Revenue Next Year
- LPCN N/A
- YMAT N/A
- P/E Ratio
- LPCN N/A
- YMAT $11.71
- Revenue Growth
- LPCN N/A
- YMAT N/A
- 52 Week Low
- LPCN $2.52
- YMAT $0.78
- 52 Week High
- LPCN $5.50
- YMAT $6.45
- Technical
- Relative Strength Index (RSI)
- LPCN 61.21
- YMAT N/A
- Support Level
- LPCN $3.07
- YMAT N/A
- Resistance Level
- LPCN $3.32
- YMAT N/A
- Average True Range (ATR)
- LPCN 0.20
- YMAT 0.00
- MACD
- LPCN 0.06
- YMAT 0.00
- Stochastic Oscillator
- LPCN 65.82
- YMAT 0.00
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About YMAT J-Star Holding Co. Ltd. Ordinary Shares
J Star Holding Co Ltd is engaged in the research, development and manufacturing of carbon fiber for a wide variety of products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products.